Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts SIG After Profit Warning

Thu, 09th Jan 2020 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

UBS RAISES INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 700 (655) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES MEGGITT PRICE TARGET TO 550 (485) PENCE - 'UNDERPERFORM'

----------

DEUTSCHE BANK RAISES ANTOFAGASTA PRICE TARGET TO 840 (820) PENCE - 'SELL'

----------

BERNSTEIN RAISES SSE PRICE TARGET TO 1600 (1450) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES CENTRICA PRICE TARGET TO 90.40 (80) PENCE - 'MARKET-PERFORM'

----------

BERNSTEIN RAISES NATIONAL GRID PRICE TARGET TO 1080 (1000) PENCE - 'OUTPERFORM'

----------

GOLDMAN CUTS UNILEVER PRICE TARGET TO 4900 (5000) PENCE - 'BUY'

----------

BERENBERG RAISES TAYLOR WIMPEY PRICE TARGET TO 230 (190) PENCE - 'BUY'

----------

BERENBERG RAISES PERSIMMON PRICE TARGET TO 3110 (2490) PENCE - 'BUY'

----------

BERENBERG RAISES BERKELEY GROUP PRICE TARGET TO 3830 (3480) PENCE - 'HOLD'

----------

BERENBERG RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 800 (670) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 275 (270) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES RIO TINTO PRICE TARGET TO 4450 (4400) PENCE - 'HOLD'

----------

SOCGEN KEEPS GLAXOSMITHKLINE 'BUY' RATING - PRICE TARGET 2300 (2200) PENCE

----------

JEFFERIES RAISES CRH PRICE TARGET TO 40.2 (38.5) EUR - 'BUY'

----------

FTSE 250

----------

PEEL HUNT CUTS SIG TO 'HOLD' ('BUY') - TARGET 115 (165) PENCE

----------

LIBERUM RAISES BALFOUR BEATTY PRICE TARGET TO 400 (350) PENCE - 'BUY'

----------

UBS CUTS COMPUTACENTER TO 'SELL' ('NEUTRAL') - TARGET 1625 (1485) PENCE

----------

UBS RAISES GREGGS PRICE TARGET TO 2640 (2300) PENCE - 'BUY'

----------

UBS RAISES AVAST PRICE TARGET TO 535 (425) PENCE - 'BUY'

----------

UBS CUTS WIZZ AIR PRICE TARGET TO 3800 (3850) PENCE - 'NEUTRAL'

----------

BARCLAYS CUTS AG BARR PRICE TARGET TO 460 (520) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS CUTS TULLOW OIL TO 'EQUAL WEIGHT' (OVERWEIGHT) - TARGET 75 (80) PENCE

----------

BARCLAYS RAISES CAIRN ENERGY PRICE TARGET TO 255 (250) PENCE - 'OVERWEIGHT'

----------

DEUTSCHE BANK CUTS FERREXPO PRICE TARGET TO 160 (200) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES KAZ MINERALS PRICE TARGET TO 610 (560) PENCE - 'HOLD'

----------

BERENBERG RAISES REDROW PRICE TARGET TO 860 (690) PENCE - 'BUY'

----------

BERENBERG RAISES MCCARTHY & STONE PRICE TARGET TO 150 (120) PENCE - 'HOLD'

----------

BERENBERG RAISES CREST NICHOLSON PRICE TARGET TO 370 (300) PENCE - 'HOLD'

----------

BERENBERG RAISES COUNTRYSIDE PROPERTIES PRICE TARGET TO 590 (440) PENCE - 'BUY'

----------

BERENBERG RAISES BELLWAY PRICE TARGET TO 4220 (3560) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ASTON MARTIN PRICE TARGET TO 400 (560) PENCE - 'HOLD'

----------

EVERCORE ISI STARTS ASTON MARTIN WITH 'UNDERPERFORM' - PRICE TARGET 350 PENCE

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES ALFA FINANCIAL SOFTWARE PRICE TARGET TO 117 (85) PENCE - 'NEUTRAL'

----------

UBS RAISES RYANAIR PRICE TARGET TO 16.30 (15.75) EUR - 'BUY'

----------

PEEL HUNT CUTS CARD FACTORY PRICE TARGET TO 110 (150) PENCE - 'REDUCE'

----------

PEEL HUNT RAISES MJ GLEESON PRICE TARGET TO 920 (800) PENCE - 'HOLD'

----------

LIBERUM RAISES MJ GLEESON PRICE TARGET TO 1050 (909) PENCE - 'BUY'

----------

BERENBERG RAISES MJ GLEESON PRICE TARGET TO 1160 (920) PENCE - 'BUY'

----------

BARCLAYS RAISES ENQUEST ENERGY TO 'OVERWEIGHT' (UNDERWEIGHT) - TARGET 40 (21) PENCE

----------

BERENBERG RAISES BREEDON PRICE TARGET TO 105 (85) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.